SUBJECTS
|
BROWSE
|
CAREER CENTER
|
POPULAR
|
JOIN
|
LOGIN
Business Skills
|
Soft Skills
|
Basic Literacy
|
Certifications
About
|
Help
|
Privacy
|
Terms
|
Email
Search
Test your basic knowledge |
First Aid Basics
Start Test
Study First
Subjects
:
health-sciences
,
first-aid
Instructions:
Answer 50 questions in 15 minutes.
If you are not ready to take this test, you can
study here
.
Match each statement with the correct term.
Don't refresh. All questions and answers are randomly picked and ordered every time you load a test.
This is a study tool. The 3 wrong answers for each question are randomly chosen from answers to other questions. So, you might find at times the answers obvious, but you will see it re-enforces your understanding as you take the test each time.
1. Larynx (SqCC) - lung (SqCC and SCC) - kidney (renal cell carcinoma) - bladder (transitional cell carcinoma)
Bombesin
Leukocyte extravasation: migration
cigarette smoke target
blood vessels benign tumor
2. Membrane lipid peroxidation - protein modification and DNA breakage.
Leukocyte extravasation: tight binding
prostate cancer incidence/mortality
Alk - phos
Free radical cell damage
3. Esophagus - stomach
Bombesin
WT1 gene
nitrosamines (smoked foods) target
Alk - phos
4. Tumor marker: prostate carcinoma marker.
Prostatic acid phosphatase
Reversible - plasias
paraneoplastic effects of SqC lung carcinoma - renal cell carcinoma and breast carcinoma.
Red (hemorrhagic) infarcts
5. Tumor marker: Hydatifiform moles - choriocarcinomas - gestational trophoblastic tumors.
beta - hCG
prostate cancer incidence/mortality
bcl -2 gene
alpha - fetoprotein
6. Colon carcinoma GTPase (oncogene)
ras gene
blood vessels benign tumor
Second - leading cause of death in the US
Rb gene
7. Lung tumor transcription factor (oncogene)
PSA
fat malignant tumor
L- myc gene
breast cancer incidence/mortality
8. Prostate (blastic) - thyroid - testes - breast (lytic and blastic) - lung (lytic) - kidney (breast and prostate are most common)
malignant >1 cell type tumor
Neoplasm associated with actinic keratosis
secondary amyloidosis (reactive systemic)
Primary tumors that met to bone
9. Infections - inflammation - cancer - pregnancy - SLE
Napthalene (aniline) dyes target
causes of increased ESR
CA-125
c - kit gene
10. Wilms' tumor 11p tumor suppressor
DPC gene
WT1 gene
bone benign tumor
Acute inflammatory mediators
11. Heart disease
p53 gene
Leading cause of death in the US
Irreversible - plasias
PSA
12. Mature teratoma in women
Irreversible - plasias
benign >1 cell type tumor
BRCA1 gene
Primary tumors that met to liver
13. Ligand - receptor interactions. Release of perforin and granzyme B.
Neoplasm associated with tuberous sclerosis (facial angiofibroma - seizures - mental retardation)
calcitonin
asbestos target
extrinsic apoptosis
14. Enzymes: catalase - superoxide dismutase - glutathione peroxidase.Vitamins: ACE Spontaneous decay
BRAC2 gene
Free radical eliminators
Neoplasm associated with actinic keratosis
alpha - fetoprotein
15. Angiosarcoma
Barrett's esophagus (chronic GI reflux)
iron poisoning
paraneoplastic effects of SqC lung carcinoma - renal cell carcinoma and breast carcinoma.
blood vessels malignant tumor
16. Tumor marker: pancreatic adenocarcinoma
Primary tumors that met to bone
immunodeficiency states
CA-19-9
benign >1 cell type tumor
17. Antibodies to presynaptic Ca2+ channels at NM junction
TRAP
paraneoplastic effects of thymoma - small cell lung carcinoma
p53 gene
fat benign tumor
18. Breast and ovarian cancer 17q tumor suppressor (DNA repair protein)
Prostatic acid phosphatase
CCl4 target
BRCA1 gene
radiation exposure
19. Neuroblastoma transcription factor (oncogene)
smooth muscle malignant tumor
paraneoplastic effects of leukemias and lymphomas
N- myc gene
Reversible - plasias
20. Adenocarcinoma - papillary carcinoma
bcl -2 gene
malignant epithelial tumor
Second - leading cause of death in the US
CA-125
21. GIST cytokine receptor (oncogene)
granulomatous disease
c - kit gene
Primary tumors that met to liver
BRCA1 gene
22. Enzymatic degradation and protein denaturation due to exogenous injury. Inflammatory process where intracellular components extravasate.
Alk - phos
APC gene
Necrosis
Neoplasm associated with xeroderma pigmentosum (albinism)
23. Vascular: E and P- selectin Leukocyte: Sialyl Lewis
Primary tumors that met to liver
Neoplasm associated with Down Syndrome
Colon and rectal cancer incidence
Leukocyte extravasation: rolling
24. Lipoma
fat benign tumor
Irreversible - plasias
blood vessels malignant tumor
Free radical cell damage
25. Tumor marker: Screen for prostate carcinoma. Can also be elevated in BPH and prostatitis.
skeletal muscle benign tumor
smooth muscle benign tumor
secondary amyloidosis (reactive systemic)
PSA
26. Burkitt's lymphoma transcription factor (oncogene)
c - myc gene
Irreversible - plasias
fat malignant tumor
prostate cancer incidence/mortality
27. ACTH or ACTH- like peptide
lung cancer incidence/mortality
iron poisoning
N- myc gene
paraneoplastic effects of small cell lung carcinoma
28. Aggressive malignant lymphomas (non - Hodgkin's) and Kaposi's sarcoma
malignant mesenchyme tumor (general)
Prostatic acid phosphatase
cirrosis (alcohol - hepB or C)
AIDS
29. Blood (leukemia)
Alkylating agents target
causes of decreased ESR
benign epithelial tumor
Leukocyte extravasation: rolling
30. Pancreatic cancer (Deleted in Pancreatic Cancer) 18q tumor suppressor
DPC gene
ret gene
DCC gene
Red (hemorrhagic) infarcts
31. Tumor marker: tartrate - resistant acid phosphatase. Hairy cell leukemia (B- cell neoplasm)
Necrosis
cigarette smoke target
TRAP
causes of decreased ESR
32. Sickle cell (altered shape) - polycythemia (too many) - CHF (unknown)
Red (hemorrhagic) infarcts
blood vessels malignant tumor
causes of decreased ESR
DCC gene
33. Squamous cell carcinoma of skin
Neoplasm associated with actinic keratosis
paraneoplastic effects of small cell lung carcinoma and intracranial neoplasms
bcl -2 gene
Autoimmune (Hashimoto's - myasthenia gravis)
34. Papillary (thyroid) - Serous (ovary) - Meningioma - Mesothelioma
Where you see Psammoma bodies
CA-125
Second - leading cause of death in the US
Leading cause of death in the US
35. Liposarcoma
TRAP
primary amyloidosis
APC gene
fat malignant tumor
36. Neurofibromatosis type 2 22q tumor suppressor (key type 2=22)
blood vessels malignant tumor
APC gene
NF2 gene
c - myc gene
37. Tumor marker: carcinoembryonic Ag Very nonspecific
c - myc gene
Neoplasm associated with Down Syndrome
calcitonin
CEA
38. Female 13% Male 12%
Colon and rectal cancer incidence
bcl -2 gene
N- myc gene
Leading cause of death in the US
39. Rhabdomyoma
AIDS
skeletal muscle benign tumor
fat benign tumor
extrinsic apoptosis
40. Liver (centrilobular necrosis - fatty change)
DPC gene
CCl4 target
aflatoxin target
Where you see Psammoma bodies
41. AL
causes of increased ESR
nitrosamines (smoked foods) target
Neoplasm associated with Down Syndrome
primary amyloidosis
42. Lung - breast - skin (melanoma) - kidney (renal cell carcinoma) - GI.50% brain tumors are from mets
skeletal muscle benign tumor
skeletal muscle malignant tumor
acanthosis nigricans (hyperpig and epidermal thickening)
Primary tumors that met to brain
43. Sarcoma - papillary thyroid cancer
ras gene
Leukocyte extravasation: tight binding
WT1 gene
radiation exposure
44. Cancer
TRAP
Leukocyte extravasation: diapedesis
Leukocyte extravasation: tight binding
Second - leading cause of death in the US
45. Tumor marker: mets to bone - obstructive biliary disease - Paget's
Resolution of inflammation
Leukocyte extravasation: migration
cirrosis (alcohol - hepB or C)
Alk - phos
46. Mature teratoma in men or malignant teratoma in M/F
DPC gene
malignant >1 cell type tumor
alpha - fetoprotein
PSA
47. Hyperplasia - metaplasia - dysplasia
fat benign tumor
aflatoxin target
skeletal muscle benign tumor
Reversible - plasias
48. Colon cancer (Deleted in Colon Cancer) 18q tumor suppressor
malignant mesenchyme tumor (general)
Rb gene
DCC gene
ret gene
49. Leiomyosarcoma
smooth muscle malignant tumor
granulomatous disease
DPC gene
Alkylating agents target
50. Hepatocellular carcinoma
cigarette smoke target
APC gene
cirrosis (alcohol - hepB or C)
paraneoplastic effects of small cell lung carcinoma